Home
Scholarly Works
Radiolabeled nanomaterials for biomedical...
Journal article

Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology

Abstract

BackgroundRecent advances in nanotechnology have offered new hope for cancer detection, prevention, and treatment. Nanomedicine, a term for the application of nanotechnology in medical and health fields, uses nanoparticles for several applications such as imaging, diagnostic, targeted cancer therapy, drug and gene delivery, tissue engineering, and theranostics. ResultsHere, we overview the current state-of-the-art of radiolabeled nanoparticles for molecular imaging and radionuclide therapy. Nanostructured radiopharmaceuticals of technetium-99m, copper-64, lutetium-177, and radium-223 are discussed within the scope of this review article.ConclusionNanoradiopharmaceuticals may lead to better development of theranostics inspired by ingenious delivery and imaging systems. Cancer nano-theranostics have the potential to lead the way to more specific and individualized cancer treatment.Graphical abstract

Authors

Pijeira MSO; Viltres H; Kozempel J; Sakmár M; Vlk M; İlem-Özdemir D; Ekinci M; Srinivasan S; Rajabzadeh AR; Ricci-Junior E

Journal

EJNMMI Radiopharmacy and Chemistry, Vol. 7, No. 1,

Publisher

Springer Nature

Publication Date

December 1, 2022

DOI

10.1186/s41181-022-00161-4

ISSN

2365-421X

Contact the Experts team